We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Compound Found in Broccoli Eliminates Breast Cancer Stem Cells

By LabMedica International staff writers
Posted on 17 May 2010
Sulforaphane, a compound found in abundance in broccoli destroys breast cancer stem cells, the extremely drug-resistant cells that often stimulate regrowth of tumors following chemotherapy.

Sulforaphane is an organosulfur compound that exhibits anticancer, antidiabetic, and antimicrobial properties. More...
It is obtained from cruciferous vegetables such as broccoli. In the plant the enzyme myrosinase transforms glucoraphanin, a glucosinolate, into sulforaphane upon damage to the plant (such as from chewing). Young sprouts of broccoli and cauliflower are particularly rich in glucoraphanin.

Investigators from the University of Michigan (Ann Arbor, USA) recently evaluated the anticancer potential of sulforaphane on breast cancer cells growing in culture and in a xenograft mouse model. They reported in the April 13, 2010, online edition of the journal Clinical Cancer Research that cultures treated with the compound showed a marked decrease in the cancer stem cell population with little effect on neighboring normal cells. Tumor cells taken from mice that had been treated with sulforaphane were unable to generate new tumors after having been transplanted into naïve animals.

"Sulforaphane has been studied previously for its effects on cancer, but this study shows that its benefit is in inhibiting the breast cancer stem cells. This new insight suggests the potential of sulforaphane or broccoli extract to prevent or treat cancer by targeting the critical cancer stem cells,” said senior author Dr. Duxin Sun, associate professor of pharmaceutical sciences at the University of Michigan.

The positive findings reported in this study support the use of sulforaphane for the chemoprevention of breast cancer stem cells, and emphasize the need for further clinical evaluation.

Related Links:

University of Michigan


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette Calibration System
Artel PCS®
Manual Pipetting Aid
Pipette Controllers macro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers developed three mathematical biomarkers from routine PSA blood tests that may help predict early prostate cancer treatment outcomes and personalize adaptive therapy (Image Credit: Adobe Stock)

Mathematical Biomarkers Use Routine Blood Tests to Guide Adaptive Prostate Cancer Therapy

Personalizing systemic therapy for prostate cancer remains challenging because tumors can evolve under treatment pressure, driving resistance and early relapse. Continuous high-dose regimens may initially... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.